ASCO 2018 - Thierry Bernard discusses the reception of QIAGEN’s QIAstat-Dx

Thierry Bernard, Senior Vice President Molecular Diagnostics, QIAGEN discusses the reception of QIAGEN’s QIAstat-Dx syndromics testing solution at ASCO, as well as future oncology applications on the device and the development of new solutions with pharmaceutical partners.